Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War
https://linktr.ee/manonthemounjaro
26 Maj 30min
Lilly Bets $8B on Weight Loss Future
https://linktr.ee/manonthemounjaro
19 Maj 23min
The Next Two Weeks in GLP1 Are Huge, Here's Why
http://www.otplinks.com
12 Maj 1h 7min
He Took Retatrutide 40mg and Proved a Point
This episode examines a serious case involving retatrutide, where an individual experienced an overdose due to improper medication administration. We discuss the critical importance of medication safe...
5 Maj 36min
Eli Lilly Earnings Call Recap: Q1 2026
We just got done listening to the quarter one, 2026 Eli Lilly earnings call. There was a lot of information to get into, whether you're interested in retatrutide, eloralintide, or Foundayo, and all of...
30 Apr 25min
SURVODUTIDE Phase 3 Data: Why Weight Loss Isn't The Whole Story
https://www.otplinks.comA new GLP-1 and glucagon agonist dropped data that was supposed to rival retatrutide, just without the GIP, and on the surface the results look solid. But that is not the real ...
28 Apr 18min
BPI STOPS TIRZEPATIDE Production, Second Major Pharmacy Out!
Major disruption hits the GLP-1 landscape as another large 503B compounding pharmacy halts production of semaglutide and tirzepatide. In this episode, we unpack what’s driving the FDA’s increased enfo...
23 Apr 40min
Retatrutide Could Change Everything… But Who Actually Gets It?
ON THE PEN RESOURCES AND LINKS: HTTPS://WWW.OTPLINKS.COMWhat if the most powerful obesity drug ever created ends up being the one you can’t get?That’s the real conversation around retatrutide right no...
21 Apr 29min
